Founded in 1953, the Mallinckrodt Foundation supports early stage biomedical investigators who conduct research that has the potential to advance the understanding, diagnosis or treatment of disease. As a 2021 grantee, Rivera-Chávez will receive $60,000 per year for three years.
The Rivera-Chávez lab Awarded Mallinckrodt Foundation Grant!
